|
Esteve-Pastor MA, Roldan V, Rivera-Caravaca JM, Ramirez-Macias I, Lip GYH, Marin F. The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal. Thromb Haemost. 2019 Dec;119(12):1901-1919. doi: 10.1055/s-0039-1696955. Epub 2019 Sep 9. PubMed PMID: 31499565.
AÑO: 2019; IF: 4.385
|
31499565
|
Vicente-Ibarra N, Marin F, Pernias-Escrig V, Sandin-Rollan M, Nunez-Martinez L, Lozano T, Macias-Villaniego MJ, Carrillo-Aleman L, Candela-Sanchez E, Guzman E, Esteve-Pastor MA, Orenes-Pinero E, Valdes M, Rivera-Caravaca JM, Ruiz-Nodar JM. Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome. Eur J Intern Med. 2019 Mar;61:48-53. doi: 10.1016/j.ejim.2018.12.004. Epub 2018 Dec 20. PubMed PMID: 30579651.
AÑO: 2019; IF: 4.329
|
|
Hernandez-Romero D, Sanchez-Quinones J, Vilchez JA, Rivera-Caravaca JM, de la Morena G, Lip GYH, Climent V, Marin F. Galectin-3 and beta-trace protein concentrations are higher in clinically unaffected patients with Fabry disease. Sci Rep. 2019 Apr 17;9(1):6235. doi: 10.1038/s41598-019-42727-4. PubMed PMID: 30996283; PubMed Central PMCID: PMC6470309.
AÑO: 2019; IF: 3.998
|
|
Vera-Catalan T, Gallego-Gomez JI, Rivera-Caravaca JM, Segura-Melgarejo F, Rodriguez-Gonzalez-Moro MT, Simonelli-Munoz AJ. A new tool to assess patients' comfort during hospitalization: The Hospital Discomfort Risk questionnaire. J Nurs Manag. 2019 Oct;27(7):1485-1491. doi: 10.1111/jonm.12834. PubMed PMID: 31349371.
AÑO: 2019; IF: 2.243
|
|
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Marín F, Lip GYH. Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA(2)DS(2)-VASc and HAS-BLED. Am Heart J. 2018 Mar;197:27-34. doi: 10.1016/j.ahj.2017.11.004. Epub 2017 Nov 10. PubMed PMID: 29447781.
AÑO: 2018; IF: 4.023
|